




Please do not adjust margins 
Please do not adjust margins 
Received 00th January 20xx, 
Accepted 00th January 20xx 
DOI: 10.1039/x0xx00000x 
 
Click-tambjamines as efficient and tunable bioactive anion 
transporters† 
Israel Carreira-Barral,a Marcin Mielczarek,a Daniel Alonso-Carrillo,a Valeria Capurro,b Vanessa 
Soto-Cerrato,c Ricardo Pérez Tomás,c Emanuela Caci,b María García-Valverdea and Roberto 
Quesada*a  
A novel class of transmembrane anion carriers, the click- 
tambjamines, display remarkable anionophoric activities in model 
liposomes and living cells. The versatility of this building block for 
the generation of molecular diversity offers promise to develop 
future drugs based on this design. 
Facilitated anion transport is an emergent topic in 
supramolecular chemistry.1 The vast majority of natural 
ionophores are cation-selective, and some of them, polycyclic 
ethers for instance, are well-known antibiotics.2 On the other 
hand, the number of compounds known to facilitate the 
transmembrane transport of anions selectively, anionophores, 
is comparatively lower.3 Moreover, our knowledge about their 
biological activities is still limited.4 Potential applications of 
these compounds include development of anticancer 
chemotherapeutics,5 as a result of the toxicity derived from an 
altered homeostasis, and as channel replacement therapies in 
conditions related to defective anion transport across the cell 
membranes such as cystic fibrosis.6 
 Several designs of active anion transporters have been 
reported in the literature.7 They usually possess an array of 
hydrogen-bond donor groups, particularly N-H fragments, 
which enable reversible anion coordination, thus forming a 
supramolecular complex capable of diffusing across the lipid 
membrane. Useful insights into anionophore design and 
function have been recently reported.8 Nevertheless, the 
discovery of easy-to-make, tunable molecular designs that 
allow extensive structure-activity relationships studies aimed at 
improving ADMET properties and modulating the balance 
between transport activity and toxicity of these molecules is key 
to develop future drugs based on this concept. 
 Inspired by the structure of secondary metabolites 
tambjamines,9 we report here a new family of compounds in 
which one of the pyrrole groups of the 4-methoxy-2,2’-bipyrrole 
core characteristic of the natural product is replaced by a 1,2,3-
triazole ring (Fig. 1). We have coined the term “click- 
tambjamines” for the resulting compounds in which 
straightforward functionalisation in both the triazole ring and 
the imine moiety allows fast generation of molecular diversity. 
 Click-tambjamines 1-9 were synthesised by condensation of 
the appropriate amine (cyclopropyl-, cyclohexyl- or 
cyclooctylamine) and the corresponding triazole-containing 
aldehyde in boiling chloroform, employing acetic acid as 
catalyst. Copper-catalysed azide-alkyne Huisgen cycloaddition 
was used to generate the aldehyde precursors bearing a triazole 
ring with appended 4-chlorophenyl-, 4-trifluoromethylphenyl- 
or 4-pentafluorosulfanylphenyl- groups (see ESI for details). The 
compounds were isolated as their hydrochloric salts and fully 
characterised. Slow evaporation of solutions of compounds 
1·HCl, 2·HCl and 5·HCl in n-butanol provided single crystals, 
suitable for X-ray diffraction analysis. In all cases the 
compounds form 1:1 adducts with the chloride anion. In the 
structures of 1·HCl and 5·HCl, the three hydrogen-bond donor 
groups of the molecules are involved in the coordination of the 
chloride anion. In the case of that of 2·HCl the C-H fragment of 
the triazole ring is oriented to the opposite direction and 
interacts with a water molecule that is coordinated to the 
chloride anion of a neighbouring complex. The N-H fragments 
of the three molecules form strong hydrogen bonds with the 
anion (the N···Cl distances fall in the range 3.05-3.25 Å, and the 
N-H···Cl angles are close to 180° (163.4-173.0°)), whereas those 
in which the triazole C-H fragment participates are weaker (the 
C···Cl distances and the C-H···Cl angles are found between 3.59 
and 3.62 Å and 144.6 and 152.7°, respectively), in agreement 
with the lower polarisation of the C-H group compared to that 
of the N-H ones.10 The core of the three compounds was found 
to be essentially
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Fig. 1 Top: from left to right, solid state X-ray structures of compounds 1, 2 and 5 as their hydrochloric salts. Solvent molecules have been omitted for the sake of simplicity. In the 
case of 5, only one of the two molecules the asymmetric unit consists of is shown. Bottom: structures of the studied compounds.    
flat, as the maximum mean deviation from planarity of the 
plane defined by the atoms of the triazole and pyrrole rings and 
the imine moiety is 0.034 Å. 
 The interaction of the protonated receptors with chloride, 
as well as with nitrate and bicarbonate, was also studied in 
solution by 1H NMR spectroscopy. Titration experiments of the 
hydroperchloric salts of compounds 1-9 with the corresponding 
tetrabutylammonium salts in DMSO-d6 were carried out. As an 
example, Fig. 2 displays the 1H NMR stack plot obtained in the 
titration of 2·HClO4 with TBACl. Upon addition of chloride, the 
signals corresponding to the protons of the imine and pyrrole 
N-H fragments as well as the triazole C-H group undergo a 
progressive deshielding, in agreement with the interaction 
found in the solid state structures of 1·HCl and 5·HCl. In order 
to quantify the binding, the association constants Ka were 
determined using the Bindfit software,11 by fitting the titration 
profiles to a 1:1 (LH:A) model, L being the receptor and A the 
anion (Table 1). The calculated values indicate that the adducts 
formed with chloride are more stable than those formed with 
nitrate, in line with the lower coordinating character of the 
latter. Bicarbonate induces deprotonation of the compounds 
and no Ka value could be ascertained in these conditions (see 
ESI). 
 Transmembrane anion transport was explored by means of 
two different techniques: potentiometry (ion-selective 
electrode, ISE) and emission spectroscopy. In all cases 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocoline (POPC) 
liposomes were employed. For the experiments involving the 
use of the chloride-selective electrode liposomes are filled with 
a sodium chloride buffered aqueous solution and they are 
suspended in an isotonic, chloride-free solution. The chloride 
efflux promoted by the studied compound is monitored over 
time and the resulting concentrations normalised by referring 
them to the total concentration of chloride in the liposomes, 
which is obtained after lysing them with a surfactant. The 
chloride efflux at 300 seconds for each concentration of 
compound employed is plotted against such concentrations and 
these data fitted with Hill equation. This fitting provides the EC50 
parameter, representing the concentration of compound 
needed to induce a 50% release of chloride.12 This parameter is 
useful for comparing the relative potency of the anionophores; 
the lower the value of the EC50, the higher the potency of the 
transporter (Table 1). The transport activity was found to be 
dependent of the substitution of the imine. The cyclooctyl-
containing compounds 3, 6 and 9 are the most active ones, 
closely followed by the cyclohexyl- derivatives 2, 5 and 8. The 
cyclopropyl- derivatives 1, 4 and 7 were found significantly less 
active (about one order of magnitude). The substituent of the 
aryl group was found to have little influence in the transport 
activity. Calculated EC50 values of the most active derivatives 
were found in the low nanomolar range, highlighting the 
extraordinary anionophoric activity of the most active click-  
Table 1 Association constants Ka (M-1) for compounds 1-9 in their protonated forms with 
chloride and nitrate (added as tetrabutylammonium salts), determined from 1H NMR 
titration experiments in DMSO-d6 at 293 K, and transport activities expressed as EC50 
(nM). 




1 220±5 11±1 136±12 2893±60 
2 240±8 4.5±0.4 32.6±0.8 130±7 
3 397±23 11±1 10±1 112±6 
4 283±9 18±2 181±20 2320±113 
5 197±6 10.3±0.9 28±2 137±37 
6 281±7 6.6±0.6 11.0±0.4 130±6 
7 278±8 11±1 238±9 3496±192 
8 755±87 12±1 32±2 236±15 
9 255±8 4.5±0.5 21±2 178±14 
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Fig. 2 Stack plot of partial 1H NMR spectra of compound 2·HClO4 in DMSO-d6 with 
addition of increasing amounts of tetrabutylammonium chloride. 
tambjamines. The observed trend in the transport activity result 
could be explained by the relative lipophilicity of the 
compounds, since 1, 4 and 7 are the less lipophilic derivatives of 
the nine studied (see calculated logP values, Table S2).13 The 
variation of the EC50 parameter when studying the chloride 
efflux in the presence of external nitrate, bicarbonate or sulfate 
is consistent with anion exchange as the main mechanism 
accounting for the transmembrane transport activity elicited by 
these compounds. Bicarbonate is less lipophilic than nitrate and 
therefore it is more difficult to extract into the lipid membrane; 
consequently, the EC50 values were found to be higher in the 
assays involving the chloride/bicarbonate exchange.  
 Emission spectroscopy experiments performed with 
carboxyfluorescein-loaded vesicles (see ESI for details) confirm 
that the anionophores do not form large non-selective pores in 
the lipid membrane, i.e., they do not behave as detergents.14 
Additional assays with the pH-sensitive fluorescent dye HPTS 
(see ESI for details) prove that these compounds efficiently 
dissipate pH gradients (Fig. 3), at concentrations as low as 
0.0001% mol carrier to lipid concentration (see ESI). 
Compounds 1, 4 and 7 are the less active of the series, whereas 
the cyclohexyl- and cyclooctyl- derivatives are the ones that 
provoke a greater alteration of the pH inside the vesicles. This 
trend is similar to that found for the ISE assays. 
 We next decided to explore the ability of these compounds 
to facilitate anion transport in living cells using Fisher Rat 
Thyroid (FRT) cells expressing a variant of the iodide-sensitive 
Yellow Fluorescent Protein (YFP).15 Thus, FRT cells transfected 
with this YFP are incubated with the compounds (or DMSO, as 
control) at 37 °C for 30 minutes, and the emission baseline 
recorded for 2 seconds. Then, a sodium iodide aqueous solution 
(at pH 6.6 or 7.3, depending on the experiment; see ESI) is 
injected and the emission measured for 20 seconds. The cellular 
internalisation of the iodide is signalled by the decay of the 
YFP’s emission. Non-active anion transporters and control 
experiments with DMSO resulted in no internalisation of iodide 
and no changes in the observed fluorescence. The quenching 
rate (QR) at different concentrations of the compounds for both 
pH values was represented against such concentrations and the 
resulting curves were fitted to a first-order binding model.16 
 
Fig. 3 Variation of pH upon addition of the studied compounds to 7:3 POPC:cholesterol 
vesicles (0.5 mM POPC). Vesicles (loaded with 126.2 mM NaNO3 buffered at pH 7.2 with 
10 mM phosphate, and containing 10 µM HPTS; I.S. 150 mM) were suspended in a NaNO3 
aqueous solution (126.2 mM NaNO3 buffered at pH 7.2 with 10 mM phosphate; I.S. 150 
mM). At t = 30 s an aliquot of a NaOH solution (11 µL, 0.5 M) was added, and at t = 60 s 
the anion carrier was added (0.0005% mol carrier to lipid concentration). The blank is 
DMSO (10 µL). Each trace represents the average of at least three trials, performed with 
three different batches of vesicles. 
This fitting provides the maximum quenching rate (mQR), which 
is a direct indication of the activity of the compound as anion 
transporter; the higher its value, the more active the carrier is 
(see ESI for a detailed procedure and the plots). Calculated mQR 
values are displayed in Table 2. The activity trend is in 
agreement with the previous results observed in liposomes. 
Thus, very limited activity was observed for the cyclopropyl- 
derivatives 1, 4 and 7, whereas cyclohexyl- and cyclooctyl- 
compounds 2, 3, 5, 6, 8 and 9 display significant activity. The 
observed transport activity increases when the assays were 
performed at a slightly acidic external pH. Both observations are 
evident in Fig. 4, where the QR values for compounds 4, 5 and 6 
are plotted against different concentrations of the compounds. 
This result is also in agreement with the demonstrated ability of 
these compounds to discharge pH gradients in liposomes and 
bodes well for potential applications in the case of cystic 
fibrosis, where an acidic airway surface liquid is a hallmark of 
the pathophysiology of this condition at the pulmonary level. 
For comparison purposes, it should be noted that the measured 
mQR of the activated wild type CFTR protein under these 
conditions is lower than 0.1 s-1.17 
Table 2 Transport activities of compounds 1-9 in FRT cells at pH 6.6 and 7.3 (outer 
medium), expressed as mQR (s–1), and cell viability IC50 (µM) of such compounds in 
human lung (A549) and breast (MCF7) adenocarcinoma cell lines and in human 
mammary epithelial (MCF10A) cell lines. 










1 0.07 0.02 41.1±16.9 34.9±12.0 23.5±9.0 
2 0.33 0.09 7.3±1.6 7.4±1.8 6.2±1.2 
3 0.32 0.16 7.1±1.1 7.6±1.7 3.7±1.7 
4 0.02 0.01 43.6±11.8 49.1±10.2 51.4±17.7 
5 0.33 0.12 n.d. n.d. n.d. 
6 0.21 0.23 7.2±0.5 7.0±1.9 4.8±2.5 
7 0.02 0.02 41.7±14.8 50.1±17.0 34.4±8.6 
8 0.37 0.29 3.5±1.1 6.1±1.3 10.7±2.2 
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Fig. 4 Representation of the quenching rate (QR) at different concentrations of 
compounds 4, 5 and 6 at pH 6.6 (left) and 7.3 (right). 
 Finally, the cytotoxicity of these compounds was analysed. 
The concentration that provokes 50% growth inhibition (IC50 
values) was determined on human lung (A549) and breast 
(MCF7) adenocarcinoma cell lines, as well as human mammary 
epithelial (MCF10A) cell lines (Table 2). Compounds 2, 3, 5, 6, 8 
and 9 display moderate cytotoxicities, with IC50 values ranging 
from 3.5 to 10.7 µM, whereas compounds 1, 4 and 7 are 
considerably less cytotoxic (from 23.5 to 51.4 µM). Little 
discrimination between normal and cancerous cell lines was 
observed. These results strongly suggest that the observed 
toxicity is related to the transmembrane transport ability of 
these compounds. On the other hand, very significant transport 
activity was observed in FRT cells for the active compounds at 
concentrations well below their IC50 values. 
 In summary, nine click-tambjamine compounds have been 
synthesised and characterised and their transmembrane anion 
transport activities in both model liposomes (POPC) and living 
cells investigated. Based on this design we have identified 
cyclohexyl- and cyclooctyl- derivatives which are remarkably 
active anion carriers in both vesicles and living cells. The 
suitability of the molecular design to produce and explore 
numerous compounds in an easy manner might constitute a 
good starting point for the design of a drug oriented to the 
treatment of anion-transport related diseases, such as cystic 
fibrosis. 
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